Search

Your search keyword '"Leukemia genetics"' showing total 8,360 results

Search Constraints

Start Over You searched for: Descriptor "Leukemia genetics" Remove constraint Descriptor: "Leukemia genetics"
8,360 results on '"Leukemia genetics"'

Search Results

1. The Leukemic Isocitrate Dehydrogenase (IDH) 1/2 Mutations Impair Myeloid and Erythroid Cell Differentiation of Primary Human Hematopoietic Stem and Progenitor Cells (HSPCs).

2. Real-World Clinical Utility of Targeted RNA Sequencing in Leukemia Diagnosis and Management.

3. Human T-cell lymphotropic virus type 1 (HTLV-1) grip on T-cells: investigating the viral tapestry of activation.

4. Genetic Analysis of De Novo Variants in KMT2A mixed-lineage leukemia Identified in a Family of Wiedermann-Steiner Syndromes.

5. Aleukemic Variant of Mast Cell Leukemia with del (7)(q31): Rare Case Report of an Elderly Chinese Man.

6. Vitamin D receptor gene polymorphisms in pediatric patients with leukemia-lymphoma: Does it have an impact on malignancy?

7. Genomic evidence of Escherichia coli gut population diversity translocation in leukemia patients.

8. Transcriptome analysis reveals a role of FOXO3 in antileukemia/lymphoma properties of panduratin A.

9. Elucidating the role of MLL1 nsSNPs: Structural and functional alterations and their contribution to leukemia development.

10. RNA m 5 C oxidation by TET2 regulates chromatin state and leukaemogenesis.

11. Genetic analysis from multiple cohorts implies causality between 2200 druggable genes, telomere length, and leukemia.

12. Slow-replicating leukemia cells represent a leukemia stem cell population with high cell-surface CD74 expression.

13. Menin inhibitors in pediatric acute leukemia: a comprehensive review and recommendations to accelerate progress in collaboration with adult leukemia and the international community.

14. Expression and putative biological roles of lipoxygenases and leukotriene receptors in leukemia and lymphoma.

15. Discovery of PRMT3 Degrader for the Treatment of Acute Leukemia.

16. Benzene exposure and pediatric leukemia: From molecular clues to epidemiological insights.

18. CRISPR-based rapid molecular diagnostic tests for fusion-driven leukemias.

19. Metabolic determinants of leukemia onset variability in genetically homogeneous AKR mice.

20. Enhancer-promoter hubs organize transcriptional networks promoting oncogenesis and drug resistance.

21. hnRNPA0 promotes MYB expression by interacting with enhancer lncRNA MY34UE-AS in human leukemia cells.

22. BOD1L mediates chromatin binding and non-canonical function of H3K4 methyltransferase SETD1A.

23. Deciphering genetic and nongenetic factors underlying tumour dormancy: insights from multiomics analysis of two syngeneic MRD models of melanoma and leukemia.

24. Oncogenic Enhancers in Leukemia.

25. The RNA helicases DDX19A/B modulate selinexor sensitivity by regulating MCL1 mRNA nuclear export in leukemia cells.

26. A potent and selective ENL degrader suppresses oncogenic gene expression and leukemia progression.

28. KMT2A Rearrangements in Leukemias: Molecular Aspects and Therapeutic Perspectives.

29. SMARCA5 reprograms AKR1B1-mediated fructose metabolism to control leukemogenesis.

30. Mechanistic insights into the developmental origin of pediatric hematologic disorders.

31. Pharmacological degradation of ATR induces antiproliferative DNA replication stress in leukemic cells.

32. [Aberrant Expression of Small Nucleolar RNA SNORA63 and Its Clinical Significance in Patients with Acute Leukemia].

33. Genomics of Plasma Cell Leukemia.

34. Star wars against leukemia: attacking the clones.

35. Targeting the sulfur-containing amino acid pathway in leukemia.

36. Ubiquitin-specific proteases (USPs) in leukemia: a systematic review.

37. [Effect of donor and recipient HLA mismatched locus on the prognosis of childhood with leukemia after umbilical cord blood transplantation].

38. Exploring the causal relationship between glutamine metabolism and leukemia risk: a Mendelian randomization and LC-MS/MS analysis.

39. Improving prediction of blood cancer using leukemia microarray gene data and Chi2 features with weighted convolutional neural network.

40. Targeting TNF/IL-17/MAPK pathway in h E2A-PBX1 leukemia: effects of OUL35, KJ-Pyr-9, and CID44216842.

41. Genetic drivers and cellular selection of female mosaic X chromosome loss.

42. Critical roles of the miR-17∼92 family in thymocyte development, leukemogenesis, and autoimmunity.

43. Changes in Telomere Length in Leukocytes and Leukemic Cells after Ultrashort Electron Beam Radiation.

44. Unraveling the molecular mechanism of novel leukemia mutations on NTRK2 (A203T & R458G) and NTRK3 (E176D & L449F) genes using molecular dynamics simulations approach.

45. SOD1 is a synthetic-lethal target in PPM1D -mutant leukemia cells.

46. Engineering an inducible leukemia-associated fusion protein enables large-scale ex vivo production of functional human phagocytes.

47. Leukemic Stem Cells and Hematological Malignancies.

48. Enhanced MAPK signaling induced by CSF3R mutants confers dependence to DUSP1 for leukemic transformation.

49. HLA-DM and HLA-DO interplay for the peptide editing of HLA class II in healthy tissues and leukemia.

Catalog

Books, media, physical & digital resources